Home » Newsletters » BioWorld Asia

BioWorld Asia

June 28, 2000

View Archived Issues

MediGene Seeking EUR125M In IPO On German Exchange

EU Drug Group Launches Unit Dedicated To Small Companies

Gene Transfer In Mosquitoes Will Aid Fight Against Malaria

British Biotech Set Back Again In Phase III Marimastat Study

NeuroSearch Spin-Off To Focus On Screening Ion Channel Drugs

UK Region Around Manchester Attracts New Businesses, Talent

BIRD-F Approves 11 Projects; Neurogenetics Unit Dedicated

Other News To Note

EU President Backs Biotech; EuropaBio Seeks New Head

EU Group Prepares Debate On Ethics Of Stem Cell Research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...